Hans Hull

Insider Reports History

Entity
Individual
Location
C/O Avalanche Biotechnologies, Inc., 1035 O'brien Drive, Suite A, Menlo Park, CA
Signature
/s/ Mike Ouimette, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hans Hull:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PLIANT THERAPEUTICS, INC. Chief Business Officer Common Stock 227K $2.63M $11.56 Jul 10, 2024 Direct
PLIANT THERAPEUTICS, INC. Chief Business Officer Common Stock 14K $162K $11.56 Jul 10, 2024 Indirect
PLIANT THERAPEUTICS, INC. Chief Business Officer Common Stock (Right to Buy) 31.4K $65.2K $2.08 Aug 4, 2023 Direct
PLIANT THERAPEUTICS, INC. Chief Business Officer Stock Option (Right to Buy) 63K Jan 23, 2024 Direct

Insider Reports Filed by Hans Hull

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PLRX PLIANT THERAPEUTICS, INC. Jul 10, 2024 1 -$114K 4 Jul 12, 2024 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Jul 9, 2024 1 $0 4 Jul 11, 2024 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Jan 23, 2024 2 $0 4 Jan 24, 2024 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Jan 17, 2024 1 -$169K 4 Jan 19, 2024 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Aug 3, 2023 7 -$605K 4 Aug 7, 2023 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Jul 17, 2023 1 -$323K 4 Jul 19, 2023 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Jul 14, 2023 1 $0 4 Jul 18, 2023 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Mar 30, 2023 1 -$240K 4 Apr 3, 2023 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Mar 29, 2023 1 $0 4 Mar 31, 2023 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Jan 25, 2023 2 $0 4 Jan 27, 2023 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Dec 19, 2022 2 -$167K 4 Dec 21, 2022 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. Jan 26, 2022 1 $0 4 Feb 2, 2022 Chief Business Officer
PLRX PLIANT THERAPEUTICS, INC. May 26, 2021 2 $9.36K 4 May 28, 2021 Chief Business Officer